|
1
|
Bahn Chair RS, Burch HB, Cooper DS, et al:
American Thyroid Association; American Association of Clinical
Endocrinologists: Hyperthyroidism and other causes of
thyrotoxicosis: management guidelines of the American Thyroid
Association and American Association of Clinical Endocrinologists.
Thyroid. 21:593–646. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Izumi Y, Takeoka K and Amino N: Usefulness
of the 2nd generation assay for anti-TSH receptor antibodies to
differentiate relapse of Graves ‘thyrotoxicosis from development of
painless thyroiditis after antithyroid drug treatment for Graves’
disease. Endocr J. 52:493–497. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kamijo K, Murayama H, Uzu T, Togashi K and
Kahaly GJ: A novel bioreporter assay for thyrotropin receptor
antibodies using a chimeric thyrotropin receptor (Mc4) is more
useful in differentiation of Graves' disease from painless
thyroiditis than conventional thyrotropin-stimulating antibody
assay using porcine thyroid cells. Thyroid. 20:851–856. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kubota S, Tamai H, Ohye H, et al:
Transient hyperthyroidism after withdrawal of antithyroid drugs in
patients with Graves' disease. Endocr J. 51:213–217. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Iitaka M, Morgenthaler NG, Momotani N, et
al: Stimulation of thyroid-stimulating hormone (TSH) receptor
antibody production following painless thyroiditis. Clin Endocrinol
(Oxf). 60:49–53. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Misaki T, Miyamoto S, Kasagi K, Mori T and
Konishi J: Serial occurrence of two types of postpartum thyroid
disorders. Usefulness of Tc-99m pertechnetate uptake. Clin Nucl
Med. 21:460–462. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nagai Y, Toya T, Fukuoka K, et al:
Occurrence and spontaneous remission of Graves' hyperthyroidism
preceded by painless thyroiditis. Endocr J. 44:881–885. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sarlis NJ, Brucker-Davis F, Swift JP,
Tahara K and Kohn LD: Graves' disease following thyrotoxic painless
thyroiditis. Analysis of antibody activities against the
thyrotropin receptor in two cases. Thyroid. 7:829–836. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Umena S, Takano T, Iijima T, et al: A case
of repeated painless thyroiditis followed by Graves' disease.
Endocr J. 42:821–826. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ho SC, Eng PH, Fok AC, Ng DC and Khoo DH:
Thyrotoxicosis due to the simultaneous occurrence of silent
thyroiditis and Graves' disease. Thyroid. 9:1127–1132. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hiraiwa T, Ito M, Imagawa A, et al: High
diagnostic value of a radioiodine uptake test with and without
iodine restriction in Graves' disease and silent thyroiditis.
Thyroid. 14:531–535. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kidokoro-Kunii Y, Emoto N, Cho K and
Oikawa S: Analysis of the factors associated with Tc-99m
pertechnetate uptake in thyrotoxicosis and Graves' disease. J
Nippon Med Sch. 73:10–17. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Osaki Y, Sakurai K, Arihara Z, Hata M and
Fukazawa H: Prediction of late (24-h) radioactive iodine uptake
using early (3-hour) uptake values in Japanese patients with
Graves' disease. Endocr J. 59:173–177. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Morris LF, Waxman AD and Braunstein GD:
Accuracy considerations when using early (four-or six-h)
radioactive iodine uptake to predict twenty-four-hour values for
radioactive iodine dosage in the treatment of Graves' disease.
Thyroid. 10:779–787. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kamijo K: Study on cutoff value setting
for differential diagnosis between Graves' disease and painless
thyroiditis using the TRAb (Elecsys TRAb) measurement via the fully
automated electrochemiluminescence immunoassay system. Endocr J.
57:895–902. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yoshimura Noh J, Miyazaki N, Ito K, et al:
Evaluation of a new rapid and fully automated
electrochemiluminescence immunoassay for thyrotropin receptor
autoantibodies. Thyroid. 18:1157–1164. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ilicki A, Gamstedt A and Karlsson FA:
Hyperthyroid Graves' disease without detectable thyrotropin
receptor antibodies. J Clin Endocrinol Metab. 74:1090–1094. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Costagliola S, Morgenthaler NG, Hoermann
R, et al: Second generation assay for thyrotropin receptor
antibodies has superior diagnostic sensitivity for Graves' disease.
J Clin Endocrinol Metab. 84:90–97. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Morita T, Tamai H, Oshima A, et al: The
occurrence of thyrotropin binding-inhibiting immunoglobulins and
thyroid-stimulating antibodies in patients with silent thyroiditis.
J Clin Endocrinol Metab. 71:1051–1055. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Amino N, Yabu Y, Miyai K, et al:
Differentiation of thyrotoxicosis induced by thyroid destruction
from Graves' disease. Lancet. 2:344–346. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Izumi Y, Hidaka Y, Tada H, et al: Simple
and practical parameters for differentiation between
destruction-induced thyrotoxicosis and Graves' thyrotoxicosis. Clin
Endocrinol (Oxf). 57:51–58. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ota H, Amino N, Morita S, et al:
Quantitative measurement of thyroid blood flow for differentiation
of painless thyroiditis from Graves' disease. Clin Endocrinol
(Oxf). 67:41–45. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tezuka M, Murata Y, Ishida R, et al: MR
imaging of the thyroid: correlation between apparent diffusion
coefficient and thyroid gland scintigraphy. J Magn Reson Imaging.
17:163–169. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zheng W, Jian T, Guizhi Z, Zhaowei M and
Renfei W: Analysis of 13 I therapy and correlation
factors of Graves' disease patients: A 4-year retrospective study.
Nucl Med Commun. 33:97–101. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang RF, Tan J, Zhang GZ, Meng ZW and
Zheng W: A comparative study of influential factors correlating
with early and late hypothyroidism after 131I therapy
for Graves' disease. Chin Med J (Engl). 123:1528–1532.
2010.PubMed/NCBI
|
|
26
|
Vitug AC and Goldman JM: Silent (painless)
thyroiditis: Evidence of a geographic variation in frequency. Arch
Intern Med. 145:473–475. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Meng Z, Zhu M and Tan J: Elephantiasis
legs. Am J Med Sci. 347:2482014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mittra ES and McDougall IR: Recurrent
silent thyroiditis: A report of four patients and review of the
literature. Tfhyroid. 17:671–675. 2007. View Article : Google Scholar
|
|
29
|
LiVolsi VA: The pathology of autoimmune
thyroid disease: A review. Thyroid. 4:333–339. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Malayeri AA, El Khouli RH, Zaheer A, et
al: Principles and applications of diffusion-weighted imaging in
cancer detection, staging and treatment follow-up. Radiographics.
31:1773–1791. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Woodhams R, Ramadan S, Stanwell P, et al:
Diffusion-weighted imaging of the breast: Principles and clinical
applications. Radiographics. 31:1059–1084. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Padhani AR, Liu G, Koh DM, et al:
Diffusion-weighted magnetic resonance imaging as a cancer
biomarker: Consensus and recommendations. Neoplasia. 11:102–125.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu Z and Xiao X: The use of multi b
values diffusion-weighted imaging in patients with acute stroke.
Neuroradiology. 55:371–376. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Della Nave R, Foresti S, Tessa C, et al:
ADC mapping of neurodegeneration in the brainstem and cerebellum of
patients with progressive ataxias. Neuroimage. 22:698–705. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pienaar R, Paldino MJ, Madan N, et al: A
quantitative method for correlating observations of decreased
apparent diffusion coefficient with elevated cerebral blood
perfusion in newborns presenting cerebral ischemic insults.
Neuroimage. 63:1510–1518. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Forbes KP, Pipe JG, Karis JP and Heiserman
JE: Improved image quality and detection of acute cerebral
infarction with PROPELLER diffusion-weighted MR imaging. Radiology.
225:551–555. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ahn SJ, Park MS, Kim KA, et al:
18F-FDG PET metabolic parameters and MRI perfusion and
diffusion parameters in hepatocellular carcinoma: A preliminary
study. PLoS One. 8:e715712013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Choi SH, Paeng JC, Sohn CH, et al:
Correlation of 18F-FDG uptake with apparent diffusion
coefficient ratio measured on standard and high b value diffusion
MRI in head and neck cancer. J Nucl Med. 52:1056–1062. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Fruehwald-Pallamar J, Czerny C,
Mayerhoefer ME, et al: Functional imaging in head and neck squamous
cell carcinoma: Correlation of PET/CT and diffusion-weighted
imaging at 3 Tesla. Eur J Nucl Med Mol Imaging. 38:1009–1019. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Nakajo M, Kajiya Y, Tani A, et al: FDG
PET/CT and diffusion-weighted imaging of head and neck squamous
cell carcinoma: Comparison of prognostic significance between
primary tumor standardized uptake value and apparent diffusion
coefficient. Clin Nucl Med. 37:475–480. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ohno Y, Koyama H, Yoshikawa T, et al: N
stage disease in patients with non-small cell lung cancer: Efficacy
of quantitative and qualitative assessment with STIR turbo
spin-echo imaging, diffusion-weighted MR imaging and
fluorodeoxyglucose PET/CT. Radiology. 261:605–615. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wu X, Pertovaara H, Korkola P, et al:
Correlations between functional imaging markers derived from PET/CT
and diffusion-weighted MRI in diffuse large B-cell lymphoma and
follicular lymphoma. PLoS One. 9:e849992014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Thoeny HC, De Keyzer F and King AD:
Diffusion-weighted MR imaging in the head and neck. Radiology.
263:19–32. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ho KC, Lin G, Wang JJ, et al: Correlation
of apparent diffusion coefficients measured by 3T
diffusion-weighted MRI and SUV from FDG PET/CT in primary cervical
cancer. Eur J Nucl Med Mol Imaging. 36:200–208. 2009. View Article : Google Scholar : PubMed/NCBI
|
